Consolidated net revenue in the quarter under review was Rs 2,688 crore as against Rs 2,192 crore in the year-ago period, up 23 per cent, it added. For the fiscal ended March 2024, consolidated profit after tax was Rs 1,638 crore compared to Rs 529 crore in the previous fiscal. Its consolidated net revenue in FY24 stood at Rs 9,286 crore over Rs 8,337 crore in FY23, the company said.
Net sales in January-March 2024 advanced 17% YoY to Rs 10,047 crore, compared to Rs 8,553 crore in the same period last year. The Board has recommended a dividend of Rs 11 per equity share for FY24. The Board has also approved the reappointment of CK Venkataraman as the MD of the company for a further period with effect from October 2024 up to December 2025. EBIT for the fourth quarter rose 8% YoY to Rs 1,139 crore, while EBIT margins declined 95 basis points to 11.1%.
Blue Star's total income increased to Rs 3,340.16 crore in Q4 FY24 as against Rs 2,830.48 crore in the similar period of the previous fiscal. Its total expenses also grew at Rs 3,126.38 crore in the fourth quarter of 2023-24, compared with Rs 2,485.46 crore in the corresponding period of the last year.
Dabur's revenue from operations in FY24 was at Rs 12,404.01 crore, up 7.58 per cent, as against Rs 11,529.89 crore a year ago. "Strong execution of our Power Brand strategy, Increased premiumization, and distribution footprint expansion coupled with the benefit of our stringent cost reduction actions helped Dabur to report a steady performance during the fourth quarter and the full year 2023-24," it said.
Procter & Gamble Hygiene and Health Care Ltd (PGHH) revenue from operations increased 13.48 per cent to Rs 1,002.17 crore during the quarter under review. It was at Rs 883.09 crore a year ago. Its Profit After Tax (PAT) of Rs 154.37 crore "was down 6 per cent vs year ago due to one-time tax impacts in the base as well as current quarters", said the earnings statement from the company which owns popular brands such as Vicks in healthcare and Whisper in feminine care.
Manyavar-owner Vedant Fashions' revenue from operations in Q4 FY24 increased to Rs 363.15 crore as against Rs 355.06 crore in Q4 FY23, as per the BSE filing.
Trent's total income has also seen a jump of 48.7 per cent to Rs 3,374.57 crore in Q4 FY24 as against Rs 2,268.06 crore in the corresponding quarter of the previous fiscal. Trent's total expenses has also increased to Rs 3,073.54 crore in Q4 FY24 as compared to the total expenses of Rs 2,207.89 crore in Q4 FY23, as per the BSE filing.
Nestle said its board approved execution of a definitive agreement to form a joint venture with Dr Reddy's Laboratories. The partners intend to bring together a global range of nutritional health solutions as well as vitamins, minerals and health supplements of Nestle Health Science. The joint venture is expected to become operational in the second quarter of the financial year 2024-25, subject to customary closing conditions, the FMCG firm said.
However, the total income during the quarter increased to Rs 15,441 crore in the fourth quarter as against Rs 15,375 crore in the corresponding quarter a year ago, HUL said in a regulatory filing.
Tata Consumer Products' total income increased to Rs 3965.39 crore in the fourth quarter ended March 2024 as against Rs 3674.03 crore in the same period of the previous fiscal year. Sunil D’Souza, managing director and CEO of the company said, “We delivered good topline growth of 10 per cent in FY24, but importantly an EBITDA growth of 24 per cent and significant expansion in EBITDA margin."
The consumer goods maker said it bagged strong growth in both its edible oils and foods businesses, aided by strong demand during the festival of Holi and ongoing wedding season.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
